Ahmet Yildiz

Ahmet Yildiz

Auto-generated profile, based on publicly available information

Ahmet Yildiz

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2017 in Nature
Verified
Journal Article
Open access
PDF file
JCJanice S. Chen
Janice S. Chen
YDYavuz S. Dagdas
Yavuz S. Dagdas
BKBenjamin P. Kleinstiver
Benjamin P. Kleinstiver
MWMoira M. Welch
Moira M. Welch
ASAlexander A. Sousa
Alexander A. Sousa
JDJennifer A. Doudna
Jennifer A. Doudna
A new engineered version of SpCas9, called HypaCas9, displays enhanced accuracy of editing without significant loss of efficiency at the desired target. One of the main concerns about the use of CRISPR in genomic editing is the possibility of 'off-target' events. Scientists have been modifying the central enzyme involved in CRISPR editing, Cas9 or its homologues, to reduce this unwanted property. Jennifer Doudna and colleagues describe a new version of this nuclease, HypaCas9, which enables more accurate editing, without substantial loss of efficiency on the desired target. The RNA-guided CRISPR–Cas9 nuclease from Streptococcus pyogenes (SpCas9) has been widely repurposed for genome editing1,2,3,4. High-fidelity (SpCas9-HF1) and enhanced specificity (eSpCas9(1.1)) variants exhibit substantially reduced off-target cleavage in human cells, but the mechanism of target discrimination and the potential to further improve fidelity are unknown5,6,7,8,9. Here, using single-molecule Förster resonance energy transfer experiments, we show that both SpCas9-HF1 and eSpCas9(1.1) are trapped in an inactive state10 when bound to mismatched targets. We find that a non-catalytic domain within Cas9, REC3, recognizes target complementarity and governs the HNH nuclease to regulate overall catalytic competence. Exploiting this observation, we design a new hyper-accurate Cas9 variant (HypaCas9) that demonstrates high genome-wide specificity without compromising on-target activity in human cells. These results offer a more comprehensive model to rationalize and modify the balance between target recognition and nuclease activation for precision genome editing.

1 July 2006 in Cell
Verified
Journal Article
Closed access
SRSamara L. Reck-Peterson
Samara L. Reck-Peterson
AYAhmet Yildiz
Ahmet Yildiz
ACAndrew P. Carter
Andrew P. Carter
AGArne Gennerich
Arne Gennerich
NZNan Zhang
Nan Zhang
RVRonald D. Vale
Ronald D. Vale

13 January 2012 in Science
Verified
Journal Article
Closed access
PDF file
MDMark A. DeWitt
Mark A. DeWitt
ACAmy Y. Chang
Amy Y. Chang
PCPeter A. Combs
Peter A. Combs
AYAhmet Yildiz
Ahmet Yildiz
Doing the Side Step: The molecular motor, dynein, contains two ring domains responsible for its movement along the microtubule. However, how the rings move relative to each other during processive motility and whether dynein processivity requires interhead coordination are unclear. To directly observe how dynein “walks” along microtubules, DeWitt et al. (p. 221 , published online 8 December) performed advanced fluorescence-imaging studies to follow both motor domains of a single dynein motor at nanometer resolution. The data suggest that the two heads do not cooperate during movement, which suggests a fundamentally different mechanism of motility from that observed for other microtubule-based motors.

8 February 2018 in Nature
Verified
Journal Article
Closed access
PDF file
LULinas Urnavicius
Linas Urnavicius
CLClinton K. Lau
Clinton K. Lau
MEMohamed M. Elshenawy
Mohamed M. Elshenawy
EMEdgar Morales-Ríos
Edgar Morales-Ríos
CMCarina Motz
Carina Motz
ACAndrew P. Carter
Andrew P. Carter

4 August 2017 in Science Advances
Verified
Journal Article
Open access
PDF file
YDYavuz S. Dagdas
Yavuz S. Dagdas
JCJanice S. Chen
Janice S. Chen
SSSamuel H. Sternberg
Samuel H. Sternberg
JDJennifer A. Doudna
Jennifer A. Doudna
AYAhmet Yildiz
Ahmet Yildiz
The Cas9 endonuclease is widely used for genome engineering applications by programming its single-guide RNA, and ongoing work is aimed at improving the accuracy and efficiency of DNA targeting. DNA cleavage of Cas9 is controlled by the conformational state of the HNH nuclease domain, but the mechanism that governs HNH activation at on-target DNA while reducing cleavage activity at off-target sites remains poorly understood. Using single-molecule Förster resonance energy transfer, we identified an intermediate state of Streptococcus pyogenes Cas9, representing a conformational checkpoint between DNA binding and cleavage. Upon DNA binding, the HNH domain transitions between multiple conformations before docking into its active state. HNH docking requires divalent cations, but not strand scission, and this docked conformation persists following DNA cleavage. Sequence mismatches between the DNA target and guide RNA prevent transitions from the checkpoint intermediate to the active conformation, providing selective avoidance of DNA cleavage at stably bound off-target sites.

25 July 2016 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
VBVladislav Belyy
Vladislav Belyy
MSMax A. Schlager
Max A. Schlager
HFHelen Foster
Helen Foster
ARArmando E. Reimer
Armando E. Reimer
ACAndrew P. Carter
Andrew P. Carter
AYAhmet Yildiz
Ahmet Yildiz
It has been unclear how the relatively weak dynein motor can counterbalance kinesin forces during microtubule-dependent transport. Belyy et al. find that binding of dynactin and BICD2 increases the strength of the dynein motor. Kinesin and dynein motors transport intracellular cargos bidirectionally by pulling them in opposite directions along microtubules, through a process frequently described as a ‘tug of war’1. While kinesin produces 6 pN of force, mammalian dynein was found to be a surprisingly weak motor (0.5–1.5 pN) in vitro, suggesting that many dyneins are required to counteract the pull of a single kinesin2. Mammalian dynein’s association with dynactin and Bicaudal-D2 (BICD2) activates its processive motility3,4,5,6, but it was unknown how this affects dynein’s force output. Here, we show that formation of the dynein–dynactin–BICD2 (DDB) complex increases human dynein’s force production to 4.3 pN. An in vitro tug-of-war assay revealed that a single DDB successfully resists a single kinesin. Contrary to previous reports, the clustering of many dyneins is not required to win the tug of war. Our work reveals the key role of dynactin and a cargo adaptor protein in shifting the balance of forces between dynein and kinesin motors during intracellular transport.